Mutations in spliceosome-associated genes were enriched in cases with thrombocytopenia compared with matched controls, whereas MPN-associated mutations (JAK2, CALR, MPL) were enriched in cases with thrombocytosis. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.